Antoine Poulet

Postmalaria Neurologic SyndromeAutoimmune Encephalitis With AntiVoltage-Gated Potassium-Channel Antibodies

P. Parola, E. Kaphan, J. Sahuguet, 2017, Annals of Internal Medicine.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

Post-malaria neurological syndrome: Imported case series and literature review to unscramble the auto-immune hypothesis.

P. Parola, H. Savini, E. Kaphan, 2019, Travel medicine and infectious disease.

Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab

G. Kaplanski, P. Jarrot, K. Mazodier, 2019, Lupus.

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

X. Mariette, J. Gottenberg, V. Devauchelle-Pensec, 2022, RMD Open.